|
SNX30 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65720004385861E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.4940999982247E-08 |
| Normal-vs-Stage2 |
1.561530E-02 |
| Normal-vs-Stage3 |
5.94570000012062E-07 |
| Normal-vs-Stage4 |
3.87210000000193E-05 |
| Stage1-vs-Stage2 |
3.686600E-01 |
| Stage1-vs-Stage3 |
5.396400E-01 |
| Stage1-vs-Stage4 |
4.698800E-01 |
| Stage2-vs-Stage3 |
2.227200E-01 |
| Stage2-vs-Stage4 |
2.000200E-01 |
| Stage3-vs-Stage4 |
8.165200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.2144999995154E-09 |
| Normal-vs-AfricanAmerican |
2.001900E-04 |
| Normal-vs-Asian |
6.02880000000194E-05 |
| Caucasian-vs-AfricanAmerican |
2.827600E-02 |
| Caucasian-vs-Asian |
5.626000E-01 |
| AfricanAmerican-vs-Asian |
1.500350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.000760E-04 |
| Normal-vs-Female |
5.78060044276185E-10 |
| Male-vs-Female |
1.314050E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.73219999957774E-08 |
| Normal-vs-Age(41-60Yrs) |
2.18439999977171E-07 |
| Normal-vs-Age(61-80Yrs) |
4.824400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.057200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.187000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.832410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.759600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.123400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.680000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.493800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.206600E-01 |
| Classical-VS-Follicular |
1.67488245494951E-12 |
| Classical-VS-Other |
1.749780E-01 |
| Classical-VS-Normal |
2.1387336346379E-12 |
| Tall-VS-Follicular |
3.52869999886707E-08 |
| Tall-VS-Other |
6.486000E-02 |
| Tall-VS-Normal |
1.4078000000195E-06 |
| Follicular-VS-Other |
2.856200E-01 |
| Follicular-VS-Normal |
6.887400E-01 |
| Other-VS-Normal |
2.375200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.964800E-04 |
| Normal-vs-N1 |
6.389900E-04 |
| N0-vs-N1 |
2.108800E-01 |
|
|
